Cargando…

Remission of intestinal Behçet's disease treated with anti-tumor necrosis factor α monoclonal antibody (Infliximab)

Behçet's disease (BD) is a chronic relapsing multisystem disease characterized by oral ulceration, genital ulceration and ocular lesions. Gastrointestinal involvement is rare, often difficult to treat and associated with a high mortality rate. We treated a 47-year-old Korean man with BD who had...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jung Hoon, Kim, Tae Nyeun, Choi, Sun Taek, Jang, Byung Ik, Shin, Kyeong-Cheol, Lee, Sam Beom, Shim, Young Ran
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2007
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687604/ https://www.ncbi.nlm.nih.gov/pubmed/17427642 http://dx.doi.org/10.3904/kjim.2007.22.1.24

Ejemplares similares

Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
por: Gulli, Salvatore, et al.
Publicado: (2003)

Efficacy and Safety of Infliximab in Intestinal Behçet’s Disease: A Multicenter, Phase 3 Study (BEGIN)
por: Cheon, Jae Hee, et al.
Publicado: (2023)

Efficacy of Calcineurin Inhibitors for Induction of Remission in Intestinal Behçet’s Disease
por: Kawaguchi, Takaaki, et al.
Publicado: (2022)

Ulcerative intestinal tuberculosis case as a complication of treatment by infliximab for intestinal Behçet's disease: A case report
por: Shen, Yan, et al.
Publicado: (2019)

Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet’s Disease
por: Park, Jihye, et al.
Publicado: (2018)

Infliximab for severe ocular inflammation in patients with Behcet's disease
por: Sfikakis, P, et al.
Publicado: (2003)

The effectiveness of the anti-tumor necrosis factor therapy infliximab in neuro-Behçet’s disease: a systematic review and meta-analysis
por: Mohammed, Reem Hamdy A, et al.
Publicado: (2023)

Infliximab is a plausible alternative for neurologic complications of Behçet disease
por: Zeydan, Burcu, et al.
Publicado: (2016)

Aortic Arch Aneurysm in Behçet Disease Successfully Treated with Infliximab
por: Nishiyama, Taihei, et al.
Publicado: (2020)

Infliximab for medical induction of remission in Crohn's disease
por: Gordon, Morris, et al.
Publicado: (2023)

Changes in the Intestinal Microbiota of Patients with Inflammatory Bowel Disease with Clinical Remission during an 8-Week Infliximab Infusion Cycle
por: Seong, Gyeol, et al.
Publicado: (2020)

The Effect of Infliximab Therapy on Maculopathy in Behcet's Panuveitis: A Case Report
por: Sahin, Ozlem G.
Publicado: (2011)

Cystoid Macular Edema: Possible Complication of Infliximab Therapy in Behçet's Disease
por: Ikewaki, Junko, et al.
Publicado: (2010)

Successful Discontinuation of Infliximab in a Refractory Case of Vasculo-Behçet Disease
por: Nakamura, Akihiro, et al.
Publicado: (2016)

Immunogenicity of Infliximab Among Patients With Behçet Syndrome: A Controlled Study
por: Esatoglu, Sinem Nihal, et al.
Publicado: (2020)

A Case of Primary Intestinal Lymphangiectasia
por: Won, Kyu Chang, et al.
Publicado: (1993)

Cataract Surgery in Behçet's Disease Patients One Week after Infliximab Administration
por: Handa, Tsuneaki, et al.
Publicado: (2011)

Trabeculotomy in a Behçet's Disease Patient One Week after Infliximab Administration
por: Koike, Aya, et al.
Publicado: (2012)

Reconstitution of disrupted photoreceptor layer in uveitis associated with Behçet’s disease by infliximab treatment
por: Takeuchi, Masaru, et al.
Publicado: (2015)

Hemorrhagic gastric ulcer in a patient with Behcet's disease successfully treated with infliximab
por: Fujiwara, Shun, et al.
Publicado: (2022)

Gallstone prevalence and risk factors in patients with ulcerative colitis in Korean population
por: Jeong, Yo Han, et al.
Publicado: (2017)

Remission of Refractory Celiac Disease With Infliximab in a Pediatric Patient
por: Rawal, Nidhi, et al.
Publicado: (2015)

Histologic discrepancy between endoscopic forceps biopsy and endoscopic mucosal resection specimens of colorectal polyp in actual clinical practice
por: Hwang, Moon Joo, et al.
Publicado: (2018)

On-demand versus half-dose continuous therapy with esomeprazole for maintenance treatment of gastroesophageal reflux disease: A randomized comparative study
por: Cho, Joon Hyun, et al.
Publicado: (2018)

Efficacy of 0.5-L vs 1-L polyethylene glycol containing ascorbic acid as additional colon cleansing methods for inadequate bowel preparation as expected by last stool examination before colonoscopy
por: Cho, Joon Hyun, et al.
Publicado: (2019)

Infliximab associated with life-threatening lung infection in a patient with Behcet disease with intestinal and hematopoietic system involvement: A case report
por: Chen, Yong, et al.
Publicado: (2017)

Erythema nodosum in Behçet’s disease in remission: Think COVID-19?
por: El Hasbani, Georges, et al.
Publicado: (2023)

Combination therapy of infliximab and thalidomide for refractory entero-Behcet's disease: a case report
por: Li, Yue, et al.
Publicado: (2013)

Efficacy of infliximab in neuro-Behçet’s disease presenting with isolated longitudinally extensive transverse myelitis
por: Kuroda, Ryo, et al.
Publicado: (2013)

Behçet's pulmonary artery aneurysms treated with infliximab and monitored with the 6-min walk test
por: Kotecha, Jalpa, et al.
Publicado: (2016)

Herpetic Keratouveitis and Trabeculectomy Failure during Infliximab Therapy in a Patient with Behçet’s Disease
por: Gür Güngör, Sirel, et al.
Publicado: (2016)

A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behçet’s syndrome
por: Horiguchi, Noe, et al.
Publicado: (2020)

Infliximab-Induced Granulomatous Vasculitis With Amyloid Deposition in the Tongue of a Patient With Behçet Disease
por: Iwasaki, Sari, et al.
Publicado: (2021)

Remission of Cap Polyposis Maintained for More Than Three Years after Infliximab Treatment
por: Kim, Eun Sun, et al.
Publicado: (2009)

A Common Bile Duct Stone formed by Suture Material after Open Cholecystectomy
por: Kim, Kook-Hyun, et al.
Publicado: (2007)

Identification of genetic susceptibility loci for intestinal Behçet’s disease
por: Kim, Seung Won, et al.
Publicado: (2017)

Association between Helicobacter pylori status and metachronous gastric cancer after endoscopic resection
por: Kim, Sung Bum, et al.
Publicado: (2016)

Intestinal Perforations in Behçet’s Disease
por: Chou, Shao-Jiun, et al.
Publicado: (2007)

PW03-012 – Unmet need in Behçet's disease: remission is rare
por: Alibaz-Oner, F, et al.
Publicado: (2013)

Development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in Behçet's disease with uveitis
por: Ishigatsubo, Y, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cvdk61rdon3p73t8oalbuo1lm7